InvestorsHub Logo
Followers 7
Posts 577
Boards Moderated 0
Alias Born 08/18/2015

Re: None

Thursday, 01/05/2017 1:15:46 AM

Thursday, January 05, 2017 1:15:46 AM

Post# of 18784
THIS WHOLE PRESS RELEASE IS INSIGNIFFICANT/MISLEADING:

Management is in bed with warrant holders (hedges) and forced to give shit out in order to get this pos moving. Shortie crooks want short and all know that the real news relarding their flagship is what matters here.

This price reaction is pure manipulation there is no reason for -38% downside based on this.

Macrilen was never the lead attempt but rather management's lowsy attampt bring something to shape otherwise quite narrow pipeline.

Zoptrex if approved will be the only FDA approved treatment for advanced, recurrent or metastatic endometrial cancer. This is signifficant, not Macrilen, never Macrilen...!!!

I buy more.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AEZS News